Shattuck Labs
  • About
    • Overview
    • Our Origins
    • Mission & Vision
    • Management
    • Board of Directors
    • Advisory Board
  • Our Science
    • ARC Platform
    • GADLEN Platform
    • Posters
    • Publications
  • Pipeline
    • Clinical
    • SL-172154 SIRPα-Fc-CD40L
    • Discovery
  • Clinical Trials
    • Overview
    • SL-172154
      • Ovarian Cancer
      • AML & HR-MDS
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • IR Resources
      • FAQS
      • Email Alerts
      • IR & Media Contact
  • Careers
    • Intro to Shattuck
    • Values
    • Benefits
    • Join Our Team
    • Current Openings
  • Contact
    • Locations
    • Contact Us

News & Events

« Previous | Next »

Shattuck’s ARC platform

Shattuck’s ARC platform was highlighted in a presentation at ASCO Breakthrough (October 11-13, 2019 in Bangkok, Thailand). An overview of the ARC platform and its unique features in comparison to monoclonal antibodies, as well as the Phase I study of SL-279252 (ClinicalTrials.gov Identifier: NCT03894618) were discussed by Dr. Johanna Bendell, Chief Development Officer of Sarah Cannon Research Institute, during her presentation on Bispecific Antibodies as part of the panel discussion on New Molecular and Immuno-Oncologic Based Therapeutics.

  • About
  • Our Science
  • Pipeline
  • Clinical Trials
  • Investors
  • Careers
  • Contact
© 2023 Shattuck Labs, Inc | Privacy | Terms of Use
logo
  • About
    • Overview
    • Our Origins
    • Mission & Vision
    • Management
    • Board of Directors
    • Advisory Board
  • Our Science
    • ARC Platform
    • GADLEN Platform
    • Posters
    • Publications
  • Pipeline
    • Clinical
    • SL-172154 SIRPα-Fc-CD40L
    • Discovery
  • Clinical Trials
    • Overview
    • SL-172154
      • Ovarian Cancer
      • AML & HR-MDS
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • IR Resources
      • FAQS
      • Email Alerts
      • IR & Media Contact
  • Careers
    • Intro to Shattuck
    • Values
    • Benefits
    • Join Our Team
    • Current Openings
  • Contact
    • Locations
    • Contact Us
  • Follow Us